Citigroup initiated coverage on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. The brokerage set a “buy” rating and a $325.00 price target on the specialty pharmaceutical company’s stock. Citigroup’s target price would suggest a potential upside of 39.88% from […]

Brookline Capital Markets assumed coverage on shares of Revolution Medicines (NASDAQ:RVMD – Get Free Report) in a research note issued on Monday, Benzinga reports. The firm set a “buy” rating and a $318.00 price target on the stock. Brookline Capital Markets’ price target suggests a potential upside of 56.09% from the stock’s previous close. Several […]

Research analysts at Craig Hallum started coverage on shares of TELA Bio (NASDAQ:TELA – Get Free Report) in a research note issued to investors on Friday, MarketBeat reports. The brokerage set a “buy” rating and a $2.00 price target on the stock. Craig Hallum’s price target would indicate a potential upside of 57.48% from the […]